Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
The primary objective of the study is to evaluate the efficacy of fasinumab compared to placebo, when administered for up to 24 weeks in patients with pain due to osteoarthritis (OA) of the knee or hip.
The secondary objectives of the study are:
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Key Inclusion Criteria (additional criteria may apply at screening):
Key Exclusion Criteria (additional criteria may apply at screening):
Primary purpose
Allocation
Interventional model
Masking
1,650 participants in 4 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal